(Q36497049)

14 August 2017

1 reference

title

Psychotic major depression: a benefit-risk assessment of treatment options (English)

1 reference

14 August 2017

1 reference

Audrey R Tyrka

1

1 reference

14 August 2017

Lawrence H Price

2

1 reference

14 August 2017

Marcelo F Mello

3

1 reference

14 August 2017

Andrea F Mello

4

1 reference

14 August 2017

Linda L Carpenter

5

1 reference

14 August 2017

publication date

1 January 2006

1 reference

14 August 2017

1 reference

14 August 2017

volume

29

1 reference

14 August 2017

issue

6

1 reference

14 August 2017

page(s)

491-508

1 reference

Psychotic (delusional) major depression: should it be included as a distinct syndrome in DSM-IV?

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2165%2F00002018-200629060-00003

The validity of major depression with psychotic features based on a community study.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002018-200629060-00003

Importance of psychotic features to long-term course in major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002018-200629060-00003

DST studies in psychotic depression: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002018-200629060-00003

Clinical and neuropsychological comparison of psychotic depression with nonpsychotic depression and schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002018-200629060-00003

Use of ECT for the inpatient treatment of recurrent major depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002018-200629060-00003

The pharmacological treatment of delusional depression

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002018-200629060-00003

Ketoconazole administration in hypercortisolemic depression

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002018-200629060-00003

Psychotic (delusional) depression: a meta-analysis of physical treatments

21 January 2018

1 reference

12 December 2020

The psychotropic effects of inhibitors of steroid biosynthesis in depressed patients refractory to treatment

1 reference

12 December 2020

Serum dopamine-beta-hydroxylase activity in clinical subtypes of depression

1 reference

12 December 2020

Antidepressant treatment of psychotic major depression: potential role of the sigma receptor

1 reference

12 December 2020

An open study of olanzapine and fluoxetine for psychotic major depressive disorder: interim analyses.

1 reference

12 December 2020

Major depression with mood-congruent psychotic features: a distinct diagnostic entity or a more severe subtype of depression?

1 reference

12 December 2020

Diagnostic confusion in treatment-refractory psychotic patients.

1 reference

12 December 2020

Depression: a case of neuronal life and death?

1 reference

12 December 2020

Clinical and biological effects of mifepristone treatment for psychotic depression

1 reference

12 December 2020

Clozapine in the treatment of psychotic refractory depression

1 reference

12 December 2020

Faster onset of action of fluvoxamine in combination with pindolol in the treatment of delusional depression: a controlled study

1 reference

12 December 2020

Limited efficacy of ketoconazole in treatment-refractory major depression.

1 reference

12 December 2020

Delusional and nondelusional unipolar depression: further evidence for distinct subtypes

1 reference

12 December 2020

Acute and long-term effectiveness of clozapine in treatment-resistant psychotic depression

1 reference

12 December 2020

Paroxetine as antidepressant in combined antidepressant-neuroleptic therapy in delusional depression: observation of clinical use.

1 reference

12 December 2020

Venlafaxine Versus Fluvoxamine in the Treatment of Delusional Depression

1 reference

12 December 2020

Delusional depression. A one year follow-up

1 reference

12 December 2020

Higher CSF levels of HVA and 5-HIAA in delusional compared to nondelusional depression

1 reference

12 December 2020

Delusional depression. A distinct clinical entity?

1 reference

12 December 2020

24-Hour monitoring of cortisol and corticotropin secretion in psychotic and nonpsychotic major depression

1 reference

12 December 2020

Elevated plasma homovanillic acid in depressed females with melancholia and psychosis

1 reference

12 December 2020

Clinical implications of imipramine plasma levels for depressive illness

1 reference

12 December 2020

Metabolic drug interactions with new psychotropic agents.

1 reference

12 December 2020

An open label trial of C-1073 (mifepristone) for psychotic major depression

1 reference

12 December 2020

Lithium augmentation in psychotic depression refractory to combined drug treatment

1 reference

12 December 2020

Olanzapine response in psychotic depression

1 reference

12 December 2020

Possible use of glucocorticoid receptor antagonists in the treatment of major depression: preliminary results using RU 486

1 reference

12 December 2020

Challenges in the treatment of depression with psychotic features

1 reference

12 December 2020

Urinary free cortisol in psychotic depression

1 reference

12 December 2020

Successful treatment of Cushing's syndrome with the glucocorticoid antagonist RU 486.

1 reference

12 December 2020

A double-blind, randomized study of olanzapine and olanzapine/fluoxetine combination for major depression with psychotic features

1 reference

12 December 2020

Psychotic and nonpsychotic depressions: I. Comparison of plasma catecholamines and cortisol measures

1 reference

12 December 2020

An 8-week open-label trial of a 6-day course of mifepristone for the treatment of psychotic depression

1 reference

12 December 2020

A meta-analysis of electroconvulsive therapy efficacy in depression.

1 reference

12 December 2020

Neuropsychological deficits in psychotic versus nonpsychotic unipolar depression.

1 reference

12 December 2020

Nefazodone in psychotic unipolar and bipolar depression: a retrospective chart analysis and open prospective study on its efficacy and safety versus combined treatment with amitriptyline and haloperidol

1 reference

12 December 2020

Psychotic symptoms and vulnerability to recurrent major depression

1 reference

12 December 2020

Serum dopamine-beta-hydroxylase activity in the affective psychoses and schizophrenia. Decreased activity in unipolar psychotically depressed patients

1 reference

12 December 2020

Depression, Delusions, and Drug Response

1 reference

12 December 2020

Candidate neuroanatomic substrates of psychosis in old-aged depression

1 reference

12 December 2020

ECT remission rates in psychotic versus nonpsychotic depressed patients: a report from CORE.

1 reference

12 December 2020

Plasma catecholamine metabolites in subtypes of major depression

1 reference

12 December 2020

The classification of depressions: a review of contemporary confusion

1 reference

12 December 2020

RU 486: a steroid with antiglucocorticosteroid activity that only disinhibits the human pituitary-adrenal system at a specific time of day

1 reference

12 December 2020

Relative Efficacy Rates for Therapies of Delusional Depression

1 reference

12 December 2020

Two-year outcome of psychotic depression in late life.

1 reference

12 December 2020

Delusional Depressions: Natural History and Response to Treatment

1 reference

12 December 2020

First experiences in combination therapy using olanzapine with SSRIs (citalopram, paroxetine) in delusional depression

1 reference

12 December 2020

Risperidone in the treatment of affective illness and obsessive-compulsive disorder.

1 reference

12 December 2020

Somatic treatment of psychotic depression: review and recommendations for practice

1 reference

12 December 2020

An open trial of olanzapine in the treatment of patients with psychotic depression

1 reference

12 December 2020

Sertraline as monotherapy in the treatment of psychotic and nonpsychotic depression

1 reference

12 December 2020

Risperidone versus haloperidol and amitriptyline in the treatment of patients with a combined psychotic and depressive syndrome

1 reference

12 December 2020

Response of psychotic and nonpsychotic depressed patients to tricyclic antidepressants.

1 reference

12 December 2020

Antiglucocorticoid treatment of refractory depression with ketoconazole: a case report.

1 reference

12 December 2020

Long-term treatment of psychotic (delusional) depression with fluvoxamine: an open pilot study

1 reference

12 December 2020

How Long Should Patients With Psychotic Depression Stay on the Antipsychotic Medication?

1 reference

12 December 2020

Relapse in delusional depression: a retrospective study of the course of treatment

1 reference

12 December 2020

Lithium-TCA combination treatment of psychotic depression: comparison with TCA-neuroleptic treatment

1 reference

12 December 2020

Cortisol circadian rhythm alterations in psychotic major depression

1 reference

12 December 2020

Primary Unipolar Depression and the Prognostic Importance of Delusions

1 reference

12 December 2020

Cortisol activity and cognitive changes in psychotic major depression

1 reference

12 December 2020

Decreased dopamine beta-hydroxylase activity in unipolar geriatric delusional depression

1 reference

12 December 2020

Effect of ketoconazole on a hypophysectomized, hypercortisolemic, psychotically depressed woman

1 reference

12 December 2020

Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial

1 reference

12 December 2020

Continuation treatment of delusional depression in older adults.

1 reference

12 December 2020

Long-term maintenance ECT: a retrospective review of efficacy and cognitive outcome

1 reference

12 December 2020

Efficacy of the combination of fluoxetine and perphenazine in the treatment of psychotic depression

1 reference

12 December 2020

Administration of RU 486 for 8 days in normal volunteers: antiglucocorticoid effect with no evidence of peripheral cortisol deprivation.

1 reference

12 December 2020

Electroconvulsive therapy in delusional and non-delusional depressive disorder

1 reference

12 December 2020

Subjective memory complaints: a review of patient self-assessment of memory after electroconvulsive therapy

1 reference

12 December 2020

The importance of psychotic features to major depression: course and outcome during a 2-year follow-up

1 reference

12 December 2020

The pharmacological treatment of delusional depression: Part II

1 reference

12 December 2020

Serum DBH activity in psychotic vs. nonpsychotic unipolar and bipolar depression

1 reference

12 December 2020

Delusional Depression and Electroconvulsive Therapy: One Year Later

1 reference

12 December 2020

Rapid reversal of psychotic depression using mifepristone

1 reference

12 December 2020

Practice guideline for the treatment of patients with major depressive disorder (revision). American Psychiatric Association

1 reference

12 December 2020

Antidepressant Drug Therapy in Psychotic Depression

1 reference

12 December 2020

Amoxapine versus amitriptyline combined with perphenazine in the treatment of psychotic depression

1 reference

12 December 2020

Selective serotonin reuptake inhibitors and delusional depression

1 reference

12 December 2020

Neuropsychological correlates of psychotic features in major depressive disorders: a review and meta-analysis

1 reference

12 December 2020

A double-blind randomized comparison of nortriptyline plus perphenazine versus nortriptyline plus placebo in the treatment of psychotic depression in late life

1 reference

12 December 2020

Treatment of psychotic depression

1 reference

12 December 2020

Synergistic action of 5-HT2A antagonists and selective serotonin reuptake inhibitors in neuropsychiatric disorders

1 reference

12 December 2020

Fifteen-year follow-up of Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition depressive disorders: the prognostic significance of psychotic features.

1 reference

12 December 2020

Use of ECT in the United States in 1975, 1980, and 1986.

1 reference

12 December 2020

Dexamethasone increases plasma free dopamine in man.

1 reference

12 December 2020

Olanzapine in the treatment of psychotic depression

1 reference

12 December 2020

Dopaminergic function and the cortisol response to dexamethasone in psychotic depression

1 reference

12 December 2020

The differentiation of DSM-III-R psychotic depression in later life from nonpsychotic depression: comparisons of brain changes measured by multispectral analysis of magnetic resonance brain images, neuropsychological findings, and clinical features

1 reference

12 December 2020

Rapid reversal of acute psychosis in the Cushing syndrome with the cortisol-receptor antagonist mifepristone (RU 486)

1 reference

12 December 2020

Consensus development conference on antipsychotic drugs and obesity and diabetes

1 reference

12 December 2020

Double-blind controlled trial of sertraline versus paroxetine in the treatment of delusional depression

1 reference

12 December 2020

Response and remission rates in different subpopulations with major depressive disorder administered venlafaxine, selective serotonin reuptake inhibitors, or placebo

1 reference

12 December 2020

The Expert Consensus Guideline Series: Medication Treatment of Bipolar Disorder 2000.

1 reference

12 December 2020

Risperidone in the treatment of disorders with a combined psychotic and depressive syndrome--a functional approach

1 reference

12 December 2020

Cortisol synthesis inhibition: A new treatment strategy for the clinical and endocrine manifestations of depression

1 reference

12 December 2020

Genotype-controlled analysis of plasma dopamine beta-hydroxylase activity in psychotic unipolar major depression

1 reference

12 December 2020

Treatment of mood-congruent psychotic depression with imipramine.

1 reference

12 December 2020

The treatment of psychotic depression in later life: a comparison of pharmacotherapy and ECT

1 reference

12 December 2020

Fluvoxamine alone in the treatment of delusional depression

1 reference

12 December 2020

Effect of Clozapine on Psychotic Depression and Parkinsonism

1 reference

12 December 2020

Psychotic depression: what is it and how should we treat it?

1 reference

12 December 2020

Efficacy of continuation ECT and antidepressant drugs compared to long-term antidepressants alone in depressed patients

1 reference

12 December 2020

Successful long-term treatment of refractory Cushing's disease with high-dose mifepristone (RU 486).

1 reference

12 December 2020

Neuropsychological deficits in psychotic versus nonpsychotic major depression and no mental illness.

1 reference

12 December 2020

Clinical results for patients with major depressive disorder in the Texas Medication Algorithm Project.

1 reference

12 December 2020

10.2165/00002018-200629060-00003

Identifiers

DOI

1 reference

Dimensions Publication ID

14 August 2017

1050873500

0 references

1 reference